Kleopas Kleopa

Prof Kleopas A. Kleopa, MD, PhD, FAAN, FEAN, is a Consultant Neurologist at the Cyprus Institute of Neurology and Genetics, where he leads the Department of Neuroscience and coordinates the Centre for Neuromuscular Disorders delivering multidisciplinary clinical care and cutting-edge therapeutics. His translational research has made significant contributions to understanding the mechanisms of neurogenetic, neuroinflammatory and neuromuscular disorders and to the development of innovative cell-targeted gene therapies for inherited neuropathies and leukodystrophies, with results currently being developed for clinical translation in collaboration with industry. His work has been widely published and recognized by numerous prestigious Awards, including the European Academy of Neurology (EAN) Investigator Award and the National Distinguished Researcher Award. He is a Board Member of the Peripheral Nerve Society (PNS) and Vice-Chair of the CMT and Related Disorders (CMTR) special interest group, as well as of the European CMT Research Association (ECRA). He serves in Scientific Advisory Boards of the USA CMT Association, the Gilbert Foundation Neurofibromatosis-1 Gene Therapy Initiative, and the PMD Foundation. He co-chairs the EAN scientific Panel on Neuropathies, as well as the Working Groups on Gene Therapies, Neuropathies, and Leukodystrophies of the European Reference Networks (ERN) for rare neuromuscular and rare neurological disorders.